Clinical Research Directory
Browse clinical research sites, groups, and studies.
Long-term Follow-up Study to Evaluate Participants With Chronic Hepatitis B (CHB) Previously Treated With AHB-137 Injection
Sponsor: Ausper Biopharma Co., Ltd.
Summary
This study is a prospective, open-label, multicenter long-term follow-up study to evaluate the durability of virologic response in subjects with chronic hepatitis B previously treated with AHB-137 injection.
Official title: Prospective, Open-label, Multicenter Long-term Follow-up Study to Evaluate the Durability of Virologic Response in Participants With Chronic Hepatitis B Previously Treated With AHB-137 Injection
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
200
Start Date
2025-08-28
Completion Date
2030-01-01
Last Updated
2026-08-18
Healthy Volunteers
No
Conditions
Locations (37)
AusperBio Investigational Site
Hefei, Anhui, China
AusperBio Investigational Site
Beijing, Beijing Municipality, China
AusperBio Investigational Site
Chongqing, Chongqing Municipality, China
AusperBio Investigational Site
Chongqing, Chongqing Municipality, China
AusperBio Investigational Site
Fuzhou, Fujian, China
AusperBio Investigational Site
Xiamen, Fujian, China
AusperBio Investigational Site
Lanzhou, Gansu, China
AusperBio Investigational Site
Foshan, Guangdong, China
AusperBio Investigational Site
Guangzhou, Guangdong, China
AusperBio Investigational Site
Guangzhou, Guangdong, China
AusperBio Investigational Site
Guangzhou, Guangdong, China
AusperBio Investigational Site
Guangzhou, Guangdong, China
AusperBio Investigational Site
Shenzhen, Guangdong, China
AusperBio Investigational Site
Shenzhen, Guangdong, China
AusperBio Investigational Site
Liuzhou, Guangxi, China
AusperBio Investigational Site
Nanning, Guangxi, China
AusperBio Investigational Site
Zunyi, Guizhou, China
AusperBio Investigational Site
Haikou, Hainan, China
AusperBio Investigational Site
Zhengzhou, Henan, China
AusperBio Investigational Site
Wuhan, Hubei, China
AusperBio Investigational Site
Changsha, Hunan, China
AusperBio Investigational Site
Changsha, Hunan, China
AusperBio Investigational Site
Changhou, Jiangsu, China
AusperBio Investigational Site
Nanjing, Jiangsu, China
AusperBio Investigational Site
Zhenjiang, Jiangsu, China
AusperBio Investigational Site
Nanchang, Jiangxi, China
AusperBio Investigational Site
Changchun, Jilin, China
AusperBio Investigational Site
Shenyang, Liaoning, China
AusperBio Investigational Site
Shanghai, Shanghai Municipality, China
AusperBio Investigational Site
Taiyuan, Shanxi, China
AusperBio Investigational Site
Xi’an, Shanxi, China
AusperBio Investigational Site
Chengdu, Sichuan, China
AusperBio Investigational Site
Chengdu, Sichuan, China
AusperBio Investigational Site
Kunming, Yunnan, China
AusperBio Investigational Site
Hangzhou, Zhejiang, China
AusperBio Investigational Site
Hangzhou, Zhejiang, China
AusperBio Investigational Site
Hangzhou, Zhejiang, China